Form 4: QuidelOrtho Executive Equity Vesting Disclosure

EVP Bryan Hanson acquired 3,508 shares of QuidelOrtho common stock via restricted stock unit vesting, with a portion withheld for taxes.

Summary

• Bryan M. Hanson, EVP of Global Portfolio Management & Marketing, acquired 3,508 shares of QuidelOrtho common stock on April 22, 2026.
• The acquisition resulted from the vesting of previously reported restricted stock units (RSUs).
• 1,269 shares were withheld by the company to satisfy tax obligations related to the vesting event.
• Following these transactions, the reporting person holds 3,139 shares of common stock directly.
• An additional 3,508 RSUs remain outstanding, scheduled to vest on April 22, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive equity compensation with no impact on company fundamentals.

Positives

• The transaction reflects the fulfillment of long-term incentive compensation for a key executive.

Negatives

• The company withheld 1,269 shares to cover tax obligations, which is a standard but non-cash-generating event for the executive.

Risks

• No specific operational or financial risks are disclosed in this ownership filing.

Future Outlook

The filing indicates that 3,508 additional restricted stock units are scheduled to vest on April 22, 2027.

Industry Context

StockSavvy.ai notes that this is a routine disclosure of executive compensation and does not signal a change in corporate strategy or market outlook.

Comparison to Industry Standards

• The vesting and tax-withholding structure is consistent with standard executive compensation practices in the healthcare and diagnostics industry.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity compensation event.

Next Steps

• Vesting of remaining 3,508 restricted stock units on April 22, 2027.

Key Dates

Keywords

QuidelOrtho, QDEL, Form 4, Insider Trading, Equity Compensation, Restricted Stock Units